{
  "entities": {
    "activities": {
      "924fafe7-22a2-4be4-9790-95db27de3105": "Bone Marrow Examination",
      "12a9a8c8-c06f-429b-be42-1bf2f24db4a6": "Bone marrow aspirate for MRD assessment",
      "5f62c716-2a70-454d-8166-036243ac318f": "Bone marrow aspirate for resistance mechanisms",
      "9030c6fa-783a-4759-b8c4-1aa9ca09c0fe": "Clonality of plasma cells (flow cytometry, IHC or IF)",
      "a52fd82e-0574-484f-a9e4-d93d93f34227": "Cytogenetic analysis (karyotype or FISH)",
      "f8587aff-93e2-4ddb-ab0a-5d00db517188": "Disease characterization (morphology, IHC, flow cytometry)",
      "d0e7fc2f-ab5f-48b9-9305-264ded257604": "Electrocardiogram",
      "8e4b3607-e3d4-47c1-94cf-29891176eb86": "Hepatitis B DNA Testing",
      "3ffdbe84-89f6-480a-b218-ca3fbe42d012": "Imaging for Lytic Disease",
      "59bee635-be58-4f86-a060-16ea8852b6b8": "Intravenous Infusion",
      "4a235036-d47a-4e29-a7e3-761a209c7ab5": "MRD and molecular subtyping",
      "4d678504-9fee-4b1d-8ece-6fbb41c6a29a": "Physical Examination",
      "fa7f7be9-2632-4fef-b65f-6f3700706246": "Plasma cell percentage in bone marrow",
      "e3428433-179c-4d69-ab57-c89cf6217e7f": "Subcutaneous Injection",
      "f1d14210-37a5-4fdb-b219-b307ce688b69": "Urine Collection",
      "44296755-01eb-41be-9330-f71cb6046a24": "Venipuncture",
      "9c1ded16-17fa-4c6d-80ba-e7e6a3093b1f": "Vital Signs Monitoring"
    },
    "plannedTimepoints": {},
    "encounters": {
      "39d104a2-0020-4d74-bc8b-c29402dd6e42": "Treatment (Post C1D1)",
      "baea8620-fb36-4aff-b539-8a91f37939a6": "Disease Progression Visit",
      "17df78ca-1a55-42cb-9af1-eab001073908": "Screening (Baseline)",
      "213bbd58-2967-43cb-88e5-b53a89d56673": "Treatment (Suspected CR/sCR)"
    },
    "epochs": {
      "65a79b77-51e2-41b4-9d6d-dced6552162a": "Screening",
      "a082236c-9153-4cc4-aa7b-0b5c81f14fed": "During Treatment",
      "594b9bd7-663f-405e-8129-b5efc888f21b": "Disease Progression"
    },
    "activityGroups": {}
  },
  "cells": {
    "f8587aff-93e2-4ddb-ab0a-5d00db517188|17df78ca-1a55-42cb-9af1-eab001073908": "both",
    "a52fd82e-0574-484f-a9e4-d93d93f34227|17df78ca-1a55-42cb-9af1-eab001073908": "both",
    "fa7f7be9-2632-4fef-b65f-6f3700706246|213bbd58-2967-43cb-88e5-b53a89d56673": "both",
    "9030c6fa-783a-4759-b8c4-1aa9ca09c0fe|213bbd58-2967-43cb-88e5-b53a89d56673": "both",
    "4a235036-d47a-4e29-a7e3-761a209c7ab5|17df78ca-1a55-42cb-9af1-eab001073908": "both",
    "12a9a8c8-c06f-429b-be42-1bf2f24db4a6|213bbd58-2967-43cb-88e5-b53a89d56673": "both",
    "12a9a8c8-c06f-429b-be42-1bf2f24db4a6|39d104a2-0020-4d74-bc8b-c29402dd6e42": "both",
    "5f62c716-2a70-454d-8166-036243ac318f|baea8620-fb36-4aff-b539-8a91f37939a6": "both"
  },
  "cellFootnotes": {
    "9030c6fa-783a-4759-b8c4-1aa9ca09c0fe|213bbd58-2967-43cb-88e5-b53a89d56673": [
      "**"
    ],
    "12a9a8c8-c06f-429b-be42-1bf2f24db4a6|213bbd58-2967-43cb-88e5-b53a89d56673": [
      "*"
    ],
    "12a9a8c8-c06f-429b-be42-1bf2f24db4a6|39d104a2-0020-4d74-bc8b-c29402dd6e42": [
      "*"
    ]
  },
  "metadata": {
    "model": "gemini-3-flash-preview",
    "extraction_type": "text"
  }
}